The CK-MM test is done in an advanced diagnostic centre known as Molecular Diagnostics and Therapy at an NABL-NABH-certified diagnostic centre. As a skeletal muscle injury evaluation test, and as part of the investigation of certain muscle disorders and certain conditions that cause injury of the skeletal muscle.
A blood sample is obtained to measure levels of CK-MM in the blood. Within tissues, CK-MM is most common in skeletal muscle. If elevated levels are found in the blood, it may indicate damage within the muscles (inflammation, trauma, or strenuous physical activity) or a muscular disorder. It must be interpreted with consideration of symptoms, patient history, routine blood tests, creatine phosphokinase, and related investigations. No one individual test can be used to determine what has caused damage in muscles.
If damage occurs within skeletal muscle fibres, CK-MM may be released into the blood. This test can be used to assess muscle damage caused by trauma, overuse, or other means.
Rhabdomyolysis causes degeneration of the skeletal muscle tissue, and therefore contents of the muscle are released into the blood. During this process, levels of CK-MM may be increased. It is very important to seek urgent medical attention, as in severe cases, kidney involvement may occur.
Muscular dystrophy is a group of genetic conditions, causing weakness within the muscles of the body. Within certain muscular dystrophies, raised levels of CK-MM in the blood may be found. This may be useful in clinical assessment.
Muscular dystrophy is a group of disorders that cause the muscles in the body to weaken and become that way due to genetics. In certain muscular dystrophies, blood levels of CK-MM may be raised, and this may also help with clinical assessment.
Within a period of heavy exercise (such as a new or challenging exercise), some muscle enzymes may be temporarily raised. If appropriate clinically, measuring CK-MM levels can help to assess the effect on muscles.
Molecular Diagnostics and Therapy provides a one-stop shop for Radiology, Nuclear Medicine, and Pathology. This allows timely, comprehensive, and coordinated diagnosis. The laboratory operates in line with procedures so that accurate testing can be performed. Each sample is carefully handled to ensure reliable results. Targeted investigations and reports can allow doctors to gain a better understanding of why a patient may have high levels of CK-MM. Patient-focused care and effective diagnostic support are guaranteed throughout.
To book a CK-MM test, please contact the centre. When taking a blood sample for CK-MM, follow the instructions given. Please bring a copy of your prescription, clinical notes, and previous notes of creatine kinase levels (if available). Fasting will not be required; however, it is important to inform your healthcare professional if you have had intense exercise recently, have recently taken medication to relieve muscle pain, or have recently taken any medications. This may affect the results of the test.
Test information: Usually, no fasting is required.
Reporting: Within 24 hours*